📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NitroMed

1.1 - Company Overview

NitroMed Logo

NitroMed

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary nitric oxide-based pharmaceuticals, leveraging substantial expertise and intellectual property in nitric oxide drug development. The company discovers, develops, and seeks to commercialize therapies based on the therapeutic benefits of nitric oxide and is conducting a late-stage confirmatory trial of its lead nitric oxide-enhancing drug, BiDil.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NitroMed

Kips Bay Medical Logo

Kips Bay Medical

HQ: United States Website
  • Description: Provider of therapeutic vascular technologies for cardiac surgeons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kips Bay Medical company profile →
Luminetx Logo

Luminetx

HQ: United States Website
  • Description: Provider of bioscience technologies, including the VeinViewer Imaging System that images vascular structures, allowing healthcare professionals to clearly see accessible vasculature in real time on the skin surface.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Luminetx company profile →
Vantis Vascular Logo

Vantis Vascular

HQ: United States Website
  • Description: Provider of vascular intervention technology for complex arteries, offering the DuoPRO™ system to navigate tortuous, calcific, and stented arteries and deliver therapeutic devices to distal coronary or peripheral anatomies. Features include the Seamless Profile low-profile tapered design, an inner microcatheter with pushability and atraumatic tip, and an outer delivery catheter enabling smooth navigation and delivery to distal lesions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vantis Vascular company profile →
Vesper Medical Logo

Vesper Medical

HQ: United States Website
  • Description: Provider of venous stenting solutions for deep venous disease, centered on the purpose-built Vesper DUO Venous Stent System, a portfolio of self-expanding nitinol stents to improve luminal diameter in symptomatic venous outflow obstructions, including DUO-HYBRID and DUO-EXTEND, and the VIVID clinical trial evaluating safety and efficacy in iliofemoral occlusive disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vesper Medical company profile →
Sanifit Logo

Sanifit

HQ: Spain Website
  • Description: Provider of biotechnology therapies for calcification disorders, developing SNF472 in phase 3 for calciphylaxis associated with chronic kidney disease and dialysis, and for peripheral artery disease in end-stage kidney disease, aiming to reduce arterial and cardiovascular calcification; supported by the CaLIPSO phase 2b trial showing significant reduction in coronary artery calcium progression in dialysis patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sanifit company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NitroMed

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NitroMed

2.2 - Growth funds investing in similar companies to NitroMed

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NitroMed

4.2 - Public trading comparable groups for NitroMed

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NitroMed

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NitroMed

What does NitroMed do?

NitroMed is a provider of proprietary nitric oxide-based pharmaceuticals, leveraging substantial expertise and intellectual property in nitric oxide drug development. The company discovers, develops, and seeks to commercialize therapies based on the therapeutic benefits of nitric oxide and is conducting a late-stage confirmatory trial of its lead nitric oxide-enhancing drug, BiDil.

Who are NitroMed's competitors?

NitroMed's competitors and similar companies include Kips Bay Medical, Luminetx, Vantis Vascular, Vesper Medical, and Sanifit.

Where is NitroMed headquartered?

NitroMed is headquartered in United States.

How many employees does NitroMed have?

NitroMed has 1,000 employees 🔒.

When was NitroMed founded?

NitroMed was founded in 2010 🔒.

What sector and industry vertical is NitroMed in?

NitroMed is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NitroMed

Who are the top strategic acquirers in NitroMed's sector and industry

Top strategic M&A buyers and acquirers in NitroMed's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NitroMed?

Top strategic M&A buyers groups and sectors for NitroMed include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NitroMed's sector and industry vertical

Which are the top PE firms investing in NitroMed's sector and industry vertical?

Top PE firms investing in NitroMed's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NitroMed's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NitroMed's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NitroMed's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NitroMed include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NitroMed's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NitroMed?

The key public trading comparables and valuation benchmarks for NitroMed include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NitroMed for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NitroMed with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NitroMed's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NitroMed with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NitroMed's' sector and industry vertical?

Access recent funding rounds and capital raises in NitroMed's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NitroMed